Organization Overview
Alternative names
Bismuth Subcitrate Potassium (Pylera) (1 trial)
bortezomib (velcade) (1 trial)
clarithromycin (biaxin) (1 trial)
cytarabine (cytosar-u) (2 trials)
daunorubicin (cerubidine) (1 trial)
drotrecogin alfa, activated (Xigris) (1 trial)
emtricitabine (emtriva) (1 trial)
epinephrine (levophed) (1 trial)
esomeprazole (nexium) (1 trial)
azacitidine (vidaza) (1 trial)
cisplatin (platinol) (1 trial)
clavulanate (Augmentin) (1 trial)
dasatinib (sprycel) (2 trials)
fluorouracil (efudex) (1 trial)
gemcitabine (gemzar) (1 trial)
iloperidone (fanapt) (1 trial)
Acute Lung Injury (Phase 2)
Adenomyosis (Phase 4)
Aortic Dissection (Phase 4)
Blast Crisis (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Colorectal Neoplasms (Phase 2)
Contracture (Phase 2)
Critical Illness (Phase 3)
Endometriosis (Phase 4)
Hemorrhage (Phase 4)
Hypotension (Phase 4)
Infertility (Phase 4)
Infertility, Female (Phase 4)
Influenza, Human (Phase 3)
Kidney Neoplasms (Phase 2)
Leukemia (Phase 3)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Lung Diseases, Obstructive (Phase 3)
Lung Neoplasms (Phase 2)
Multiple Myeloma (Phase 3)
Myotonic Dystrophy (Phase 3)
Nausea (Phase 4)
Neoplasms, Plasma Cell (Phase 3)
Pain, Postoperative (Phase 4)
Philadelphia Chromosome (Phase 2)
Pneumonia (Phase 3)
Pneumonia, Viral (Phase 3)
Postoperative Nausea and Vomiting (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 3)
Respiratory Distress Syndrome (Phase 2)
Respiratory Distress Syndrome, Newborn (Phase 2)
Respiratory Insufficiency (Phase 2)
Sepsis (Phase 3)
Shock (Phase 3)
Shock, Septic (Phase 3)
Tendinopathy (Phase 2)
Torticollis (Phase 2)
Ureteral Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Vomiting (Phase 4)